Ixifi (infliximab-qbtx) / Sandoz, Pfizer, Novartis  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ixifi (infliximab-qbtx) / Pfizer, Sandoz
REFLECTIONS B537-02, NCT02222493 / 2013-004148-49: A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis ().

Checkmark REFLECTIONS B537-02 trial
Jul 2018 - Jul 2018: REFLECTIONS B537-02 trial
Completed
3
650
Japan, US, Canada, Europe, RoW
PF-06438179, Infliximab-Pfizer, Infliximab, Infliximab-EU, Remicade
Pfizer
Rheumatoid Arthritis
06/16
06/17

Download Options